Skip to content
Recall Observatory FDA recall evidence

Device product

MAS CardioImmune XL Cardiac Marker Control; Model: CAI-XL1; intended for use in the clinical laboratory as an assayed control serum for monitoring assay conditions in specific cardiac marker determinations.

Z-0501-2015

October 20, 2014

Class II

Product summary

Firm
Microgenics Corporation
Event
Event 69670
Status
Terminated
Classification
Class II
Quantity
2135 vials.
Official record key
device-enforcement:Z-0501-2015

Official wording

Reason: MAS CardioImmune XL, level 1 (lot CXL16011), is showing vial-to-vial variation for the analytes Creatine Kinase-MB (CK-MB) and B-Type Natriuretic Peptide-32 (BNP-32).

Code information: Model No.: CAI-XL1; Lot Number: CXL16011, Exp. Date: 2016-01-31.

Distribution pattern: Worldwide Distribution - USA (nationwide) including Puerto Rico and the states of AR, AZ, CA CO, CT, DE, FL GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NJ, NM, NV, NY, OH, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WI and WY., and the countries of Australia, Canada, China, Germany, Guam, Hong Kong and Taiwan.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    MAS CardioImmune XL, level 1 (lot CXL16011), is showing vial-to-vial variation for the analytes Creatine Kinase-MB (CK-MB) and B-Type Natriuretic Peptide-32 (BNP-32).